Header Logo

Connection

WILLIAM PEACOCK to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Back to Details
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
WILLIAM PEACOCK
Connection Strength
0.019
Hydroxymethylglutaryl-CoA Reductase Inhibitors
  1. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. Acad Emerg Med. 2015 May; 22(5):554-63.
    View in: PubMed
    Score: 0.019
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.